Pneumologische Praxis am Schloss Charlottenburg
- Address
- Spandauer Damm 3, 14059 Berlin, Germany
Pneumologische Praxis am Schloss Charlottenburg
Pneumologische Praxis am Schloss Charlottenburg is a specialized respiratory medicine center dedicated to advancing the treatment of chronic pulmonary conditions through clinical research. The practice focuses on investigating innovative therapeutic approaches for patients with Chronic Obstructive Pulmonary Disease (COPD) and related respiratory disorders, with particular emphasis on improving patient outcomes and reducing disease exacerbations.
- Chronic Obstructive Pulmonary Disease (COPD) treatment optimization
- Advanced triple therapy maintenance protocols combining ICS, LABA, and LAMA
- Novel pharmaceutical interventions for chronic bronchitis management
- Exacerbation prevention strategies in chronic respiratory diseases
The center's research initiatives evaluate cutting-edge add-on therapies to standard maintenance triple therapy regimens, focusing on long-term efficacy and safety outcomes over extended treatment periods. Their clinical trial work contributes valuable evidence for improving quality of life and reducing the burden of moderate and severe exacerbations in patients with chronic respiratory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pneumologische Praxis am Schloss Charlottenburg
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation. | Glaxosmithkline Research & Development Limited | Phase III | Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Depemokimab | 1 | Unknown | 2026-01-20 | 2026-01-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.